Overview

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

Status:
Completed
Trial end date:
2007-08-29
Target enrollment:
Participant gender:
Summary
This study was designed to compare the effectiveness and tolerability of a new prolonged release formulation of ropinirole with the currently marketed immediate release formulation which is prescribed in many countries. The new prolonged release formulation allows the drug to be taken once a day rather than three times a day. This study will also evaluate the side effects of the new prolonged release formulation of ropinirole
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole